We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients

News   Jul 15, 2020 | Original story from Keck Medicine of USC

 
Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients

Keck Medicine of USC physicians are participating in a clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19. Credit: Ricardo Carrasco III

 
 
Advertisement
 

RELATED ARTICLES

To Prevent Another Pandemic, Air Must Be Regulated Like Food and Water

News

Researchers say that the air we breathe inside buildings needs to be more highly regulated to reduce disease transmission and prevent the next pandemic.

READ MORE

Delaying Second COVID-19 Vaccine Dose May Prevent Deaths, Under Certain Conditions

News

A study has found that delaying the second dose of covid-19 vaccines, at least for people aged under 65, could result in up to 20% lower mortality, but only under certain conditions.

READ MORE

Skin-Patch Vaccine for Dengue Fever Successful in Preclinical Models

News

A dengue virus vaccine candidate has shown promising results in animal models, producing a protective immune response in dengue-infected mice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE